Neonatal sympathectomy reduces arterial pressure in spontaneously hypertensive rats (SHR).
3
The kidney and the sympathetic nervous system contribute to the pathogenesis of arterial hypertension in spontaneously hypertensive rats (SHR) (12) . Arterial pressure can be chronically lowered in SHR by neonatal sympathectomy (19, 21) and renal mechanisms are involved in this chronic arterial pressure reduction (14) . We have shown that SHR transplanted with a kidney from sympathectomized SHR donors had lower arterial pressure than SHR recipients of a kidney from hydralazine-treated SHR donors (14) . In addition, sodium sensitivity of arterial pressure was lower in recipients of a kidney graft from sympathectomized donors than in recipients of a graft from hydralazine-treated donors (14) .
The present study was performed to identify mechanisms that may explain these findings and we therefore focused on kidneys from sympathectomized and hydralazine-treated SHR.
Limited data is available on chronic effects of neonatal sympathectomy on SHR kidneys.
Thus, we initially tested for differential mRNA expression of nine a priori selected genes in kidneys from sympathectomized and hydralazine-treated SHR exposed to three different experimental conditions. This was done to identify alterations in gene expression that persist under different conditions and that therefore may be involved in chronic effects of neonatal sympathectomy. The choice of genes was based on the results from comparative studies in spontaneously hypertensive and normotensive rats relevant for the present experimental paradigm.
From the renin-angiotensin system we chose the AT 1 receptor and renin. Glomerular and tubular AT 1 receptor expression was higher in newborn and juvenile SHR than in normotensive rats (5, 15) . Renal renin mRNA expression was more sensitive to renal denervation in young SHR than in normotensive rats (25). The renal endothelin system contributes to the pathogenesis of sodium-sensitive hypertension (27) including SHR (31).
Therefore we tested for differential endothelin-1 (ET-1), ET A and ET B receptor mRNA expression. From oxygen radical generating systems we included the p47phox subunit of the Page 3 of 33 
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NADPH oxidase because its renal expression and the NADPH oxidase activity were higher in SHR than in normotensive rats (1, 4) . Furthermore, we tested for differential expression of cyclooxygenase 2 (COX-2), endothelial nitric oxide synthase (eNOS) and neuronal nitric oxide synthase (nNOS). Altered renal expression and function of these enzymes or decreased renal availability of their products is involved in the pathogenesis of experimental hypertension (9, 23, 39, 41, 44) . COX-2 expression is developmentally regulated in rat kidneys (45) and renal nNOS expression and function depend on renal innervation (16, 41) .
The screening for differential mRNA expression revealed the most prominent changes for the the NADPH oxidase subunit p47phox. The NADPH oxidase is a major source of renal oxygen radical production (39) and arterial hypertension can be efficiently treated with antioxidants in SHR (32, 43) . Increased renal oxygen radical formation can contribute to the development and maintenance of hypertension by elevating renal vascular resistance, tubulo-glomerular feedback sensitivity and tubular sodium reabsorption (26, 32, 39) . Currently, little information is available on the influence of the sympathetic nervous system on renal NADPH oxidase expression and activity. We therefore tested the hypothesis that neonatal sympathectomy reduces renal mRNA expression of NADPH oxidase subunits other than p47phox that are necessary for NADPH oxidase enzyme activity. Further, we tested the hypothesis that neonatal sympathectomy causes a reduction in renal NADPH oxidase activity in young SHR.
We found that NADPH oxidase activity was reduced both in the renal cortex and medulla of young sympathectomized SHR. Therefore we tested the hypothesis whether this reduction of renal NADPH oxidase activity is associated with chronic changes in renal function that would persist in transplanted kidneys and may help to explain the long-term renal effects of neonatal sympathectomy on arterial pressure in SHR (14) .
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Materials and methods
Animals
Male and female SHR were obtained from M & B, Ry, Denmark. First generation offspring were bred in our temperature-and humidity-controlled animal facility with lights on from 06.00 am to 06.00 pm. If not stated otherwise (protocol 2) animals were fed a standard rat chow containing 0.6% NaCl. All diets used in this study were from Ssniff, Soest, Germany.
Rat pups were subjected to either neonatal sympathectomy consisting of intraperitoneal injections of guanethidine (50 Lg/g body wt) and surgical removal of adrenal medullary tissue on postnatal day 28 or to sham-treatment as described and validated previously (14) .
Hydralazine was administered at 50 mg/kg body weight via the drinking water starting on postnatal day 28 and continued until the end of postnatal week 10. Male animals were used for experimentation. All procedures were approved by a governmental committee on animal welfare. Its guidelines are in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The animals underwent three different experimental protocols.
Protocol 1:
Ten-week-old sympathectomized and hydralazine-treated SHR were anesthetized with ether and kidneys were rapidly removed, blotted and cut in slices on a Petri dish cooled with ice.
Tissue slices were dissected into cortex and medulla. Medullary specimens contained the inner stripe of the outer medulla and the inner medulla. After dissection, tissue samples were snap frozen in liquid nitrogen and stored at -70°C until further analysis. Identically treated 10-week-old SHR had been used as kidney donors in previous renal transplantation studies (14) .
Seven weeks after transplantation, the kidney grafts of that study (14) had been dissected into cortex and medulla and stored at -70°C. These tissue samples were included in the gene Page 5 of 33 6 expression analyses of the present study. Measurements of NADPH oxidase activity were performed in tissues of a separate set of animals consisting of sympathectomized, hydralazine-treated and untreated SHR. The kidneys of untreated SHR consisted of the left native kidneys which were removed from the recipients prior to renal transplantation (protocol 3) (13, 14) .
Protocol 2:
To investigate the effect of a sodium load on arterial pressure and on renal gene expression sympathectomized, hydralazine-treated and sham-treated SHR were implanted with radiotelemetric arterial pressure recording devices (TA11PA-C40, Data Scienecs International, St. Paul, MN) at 10 weeks of age. Hydralazine treatment was stopped on the day of transmitter implantation. The sham-treated group was included to verify that SHR were indeed hypertensive and to quantify the antihypertensive effects of hydralazine-treatment and neonatal sympathectomy by telemetry. After one week of recovery, only sympathectomized and hydralazine-pretreated animals were transferred into metabolism cages and placed on a diet containing 0.12% NaCl. After a 3-day adaptation period, urine collections and telemetric recordings were performed. After a three-day data collection period on 0.12% NaCl, animals were fed a 1.8% NaCl diet for another 4 days similar to the preceding study in renal transplanted SHR (14) . Arterial pressure was recorded and analyzed as described previously (13, 14) . Telemetric data are given as 12 hour mean values. At the end of these experiments, kidneys were harvested as described for protocol 1 for gene expression analysis.
Protocol 3:
To investigate renal function in greater detail as possible in conscious, chronically instrumented rats (14) , kidneys from sympathectomized and hydralazine-treated SHR were transplanted into untreated SHR recipients. Both native kidneys of the recipients were 7 removed (13, 14) . Seven weeks after transplantation, animals were instrumented for acute renal function studies after an overnight fast. At this time, the animals were 17-18 weeks old and body weight was 300-350g with no difference between groups. Rats were anesthetized with pentobarbital sodium 50 mg/kg i.p. and placed on a servo-controlled heating pad.
Catheters for infusion and supplemental administration of anesthetics were inserted into the right jugular and right femoral vein. Arterial pressure was recorded via a catheter placed into the right carotid artery. A cannula was placed into the trachea and animals were artificially ventilated after administration of 1 mg/kg pancuronium bromide. The renal graft was approached via an abdominal midline incision, carefully cleaned from surrounding tissue without damaging the renal capsule and placed into a small plastic holder filled with gauze to prevent movements. The kidney was covered and kept moist with prewarmed isotonic saline.
A transit time ultrasound probe (type 1RB, Transonic Systems, Ithaca, NY) was placed around the renal artery of the graft. Proper acoustic coupling was achieved with ultrasonic gel.
The superior mesenteric artery was cleared from surrounding tissue and a suture was placed loosely around the vessel to facilitate rapid occluding of the vessel with a small vessel clamp to elevate arterial pressure. With the aid of a stereotactic apparatus a Laser Doppler probe (type 418-2, Perimed, Järfälla, Sweden) was advanced rectangular to the frontal plane 5mm deep into the renal tissue to record renal medullary flow. Prior to insertion of the Laser Doppler probe, the renal capsule was perforated with a 26 gauge needle at the insertion site. A PE 10 catheter was placed into the ureter to collect urine for measurements of inulin clearance and renal sodium excretion.
Animals were infused with isotonic saline containing inulin (3.3 mg/ml) and 2% bovine serum albumin at a rate of 5.66 ml/hour starting during abdominal surgery. After a 45 min equilibration period post surgery, data on arterial pressure and renal function were collected over a 20 min period. Thereafter, the superior mesenteric artery was occluded which caused a 
Renal mRNA expression
Total RNA was isolated with the acid-guanidium-thiocyanate-phenol-chloroform procedure using the TRIzol Table   1 ). The PCR included a 10 min activation of the DNA polymerase at 95°C, 40 cycles at 95°C for 15s for denaturation, and 1min at 60°C for annealing and extension.
PCRs were performed in triplicate. Quantification of gene expression was performed with the standard curve method. Standard curves (C T plotted vs. log of concentration) for target genes and for the endogenous reference were generated from a serially diluted cDNA pool of all tested samples. Expression levels are given relative to PBGD mRNA. In each experimental plate a no-template control was included to check for any contamination disturbing PCR. It was also confirmed that no amplification occurred when samples were not subjected to reverse transcription, indicating the absence of genomic DNA after DNAse treatment.
Sequences of primers and TaqMan probes are given in the on-line supplement.
Identity of the gene specific PCR products was confirmed by size estimation using standard agarose gel electrophoresis and ethidium bromide staining as well as by sequencing of PCR products (Invitek & Biodesign, Berlin, Germany; SEQLAB, Göttingen; Germany). For purification of PCR products, commercial gel band extraction kits (e.g. MinElute ™ Gel extraction Kit, Qiagen, Hilden, Germany) were used. Sequencing was performed with the same oligonucleotide primers as used for real-time PCR.
NADPH oxidase activity
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Renal NADPH oxidase activity was measured by lucigenin enhanced chemiluminescence in renal tissue from ten-week-old SHR. Tissue preparation followed an established procedure (24) to obtain the membrane fraction. Tissues where homogenized in PBS containing a proteinase inhibitor cocktail (Sigma), 0.1% (v/v) 2-mercaptoethanol, 0.01 mmol/l EDTA, 1 mmol/l phenylmethanesulfonyl fluoride (PMSF) and 1% (w/v) BSA. After stepwise centrifugation of the homogenate at 500, 25000 and 100000g, the resulting pellet was resuspended in PBS containing 1% BSA. Enzyme activity was measured in triplicate in aliquots of the pellet corresponding to 18 mg (renal cortex) or 7.2 mg (renal medulla) wet tissue weight with a luminometer (Microlumat Plus, Berthold, Bad Wildbad, Germany) in the presence of 5 Lmol/l lucigenin, 100 Lmol/l L-NAME, 100 Lmol/l allopurinol and 50 Lmol/l rotenone. After 60 s of baseline recording, NADPH (final concentration 300 Lmol/l) was added to the reaction mixture. Thereafter, every 6 seconds a luminescence reading was obtained for an overall measuring time of 9 min. To control for specificity, simultaneous runs containing either 50 Lmol/l diphenyliodonium (DPI) or 20 mmol/l tiron were performed for each measurement. Enzyme activity is expressed in relative light units (RLU) per min and mg wet tissue weight.
Histology
Paraffin-embedded tissue samples were cut into 2 Lm slices and stained with hematoxylineosin. To specifically visualize leukocytes, tissue sections were also stained for leukocyte specific naphtole AS-D chloracetate esterase and counterstained with hematoxylin.
Histological examination was performed by a pathologist (G.L.) who was blinded to the experimental design.
Statistics
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Data were analyzed with an analysis of variance (two-way ANOVA, two-way ANOVA for repeated measurements, one-way ANOVA) as appropriate followed by post hoc t-tests with Bonferroni correction. Since the three sets of tissue samples for gene expression analyses were obtained on separate occasions, statistical analyses of renal gene expression data were restricted to group comparisons within each experimental protocol. Differences were considered statistically significant when p < 0.05. Data are given as means ± SEM.
Results
Renal gene expression
Analysis of renal cortical gene expression revealed no statistically significant differences between 10-week-old sympathectomized and hydralazine-treated animals and no differences between kidney grafts from sympathectomized and hydralazine-treated donors (protocol 1) for the nine selected genes (Table 1) . After high NaCl diet and hydralazine withdrawal (protocol 2), cortical COX-2 expression was 138 % (p < 0.01) and renin expression was 74 % (p < 0.05) in cortices of sympathectomized animals relative to hydralazine-treated animals (Table 1) . One week after implantation of radio telemetric devices (protocol 2), average daytime arterial pressure was 149 ± 7 over 107 ± 6 mmHg in sympathectomized SHR and 142 ± 7 over 104 ± 8 mmHg in SHR which had been taken off hydralazine at the time of transmitter implantation. Arterial pressure was significantly higher in sham-treated animals (165 ± 5 over 127 ± 5 mmHg) than in the other groups (p < 0.01). Changes in sodium chloride intake did not differentially affect arterial pressure in sympathectomized and hydralazine-pretreated animals. Sympathectomized animals transiently retained more sodium after initiation of the high salt feeding (p < 0.05, Fig. 1 ) which is in line with the established fact that intact regulation of renal innervation facilitates renal excretion of an acute sodium load (8) . Heart Page 11 of 33 rate was higher in sympathectomized than in hydralazine-treated animals to compensate for compromised sympathetic regulation of peripheral vascular resistance (p < 0.001).
Renal medullary samples obtained from these experimental groups showed more differences in gene expression than cortical samples (Table 2) . Medullary renin mRNA expression in sympathectomized SHR was 56% of the expression level in hydralazine-treated SHR at 10 weeks of age (p < 0.005). Furthermore, medullary pre-pro-ET-1 and ET A receptor mRNA expression was lower in kidneys from sympathectomized animals than in kidneys from hydralazine-treated animals while ET B receptor mRNA expression was less in renal grafts from sympathectomized animals. The between group differences in mRNA expression of the endothelin system components were in the range of 20-25%. Depending on the experimental conditions we observed differences also in medullary nNOS and eNOS expression. Under all experimental conditions renal medullary p47phox mRNA expression was lower in sympathectomized SHR than in hydralazine-treated SHR. In kidney grafts this difference failed to reach statistical significance.
Among the nine genes investigated, renal medullary p47phox showed the largest differences in mRNA expression levels between sympathectomized and hydralazine-treated groups.
These differences were robust and were observed under three different experimental conditions (10-week-old SHR, 13-week-old SHR after 1.8% NaCl, transplanted SHR). These observations prompted us to investigate the effects of neonatal sympathectomy on NADPH oxidase subunits in greater detail (Table 3 ). In addition to medullary p47phox mRNA expression, medullary gp91phox mRNA expression was also reduced in native kidneys from 10-week-old sympathectomized rats compared to hydralazine-treated animals. Among the NOX isoforms, NOX4 expression was highest in the cortex and lowest in the medulla in all Page 12 of 33 experimental groups (Table 3) . Furthermore, p22phox mRNA expression was less in the medulla than in the cortex.
Histological examination was performed to exclude that the differences in medullary p47phox and gp91phox mRNA expression were due to differential leukocyte infiltration in the kidneys of sympathectomized and hydralazine-treated animals. There were no apparent morphological differences in kidneys from sympathectomized and hydralazine-treated SHR (Fig. 2) .
Morphology of the grafts used for gene expression analyses has been published previously (14) . Measurements of renal copper zinc (SOD1) and extracellular (SOD3) superoxide dismutase mRNA expression revealed no significant group differences in 10-week-old animals ( Tables 1 and 2 ).
NADPH oxidase enzyme activity
To examine the impact of neonatal sympathectomy on NADPH oxidase function, measurements of enzyme activity were performed in kidneys from 10-week-old SHR.
NADPH oxidase activity was lower in both renal cortex and medulla of sympathectomized animals compared to hydralazine-treated as well as untreated controls (Fig. 3) . NADPH oxidase activities in kidney grafts from sympathectomized and hydralazine-treated donors obtained 7 weeks after transplantation and after completion of acute experiments (see below)
were not significantly different between both groups (data not shown).
Renal function
Experiments on renal function in transplanted kidneys showed that RBF, GFR and fractional sodium excretion were similar in both groups under baseline conditions and after nonpharmacological arterial pressure elevation (Fig. 4) . In both groups fractional sodium excretion was significantly increased in response to increased renal perfusion pressure (p < Page 13 of 33 0.05) while MBF did not significantly change (Fig. 4) . Renal vascular resistance was significantly lower (p < 0.05) in kidney grafts from sympathectomized animals than in grafts from hydralazine-treated animals (Fig. 5) .
Discussion
The present study was performed to identify renal mechanisms that are involved in the chronic arterial pressure reduction in SHR induced by neonatal sympathectomy (14) . Since limited data are available on the effects of neonatal sympathectomy on SHR kidneys, the study was initiated with a screening for differentially expressed genes to allow simultaneous Neonatal sympathectomy reduced arterial pressure by approximately 20 mmHg but not to normotensive levels indicting that in addition to elevated sympathetic activity other mechanisms contribute to hypertension in SHR. Chronically instrumented rats studied 10 days after drug washout showed no difference in sodium sensitivity of arterial pressure.
Interestingly, hydralazine-treated animals showed a persistent arterial pressure reduction after treatment was stopped. This finding indicates that in SHR hydralazine given early after birth has a similar prolonged antihypertensive action as sympatholytic drugs (14, 19) or ACEinhibitor treatment (34) . In keeping with this observation, radiotelemetric studies have shown that the combination of hydralazine with a diuretic and a calcium antagonist lowers arterial pressure for several weeks beyond cessation of drug administration in adult SHR (40) . The different potency of these treatments to induce chronic changes in renal function that contribute to the maintenance of the arterial pressure reduction becomes apparent in transplantation experiments (14, 34) . While transplantation of a kidney from sympathectomized or ACE-inhibitor-treated SHR donors confers persistent lowering of arterial pressure in SHR recipients (14, 34) , transplantation of a kidney from hydralazinetreated SHR donors is associated with a slow but distinct recovery of arterial pressure in SHR recipients (14) .
The mechanisms underlying the chronic arterial pressure lowering effect of renal grafts from sympathectomized SHR (14) advantage that the function of kidneys from sympathectomized and hydralazine-treated SHR can be studied in a neurohormonal environment that is as similar as possible in both experimental groups (13) . Confounding effects of differences in sympathetic tone that are hard to eliminate by hormone clamping when native kidneys are studied can be avoided.
Under acute experimental conditions with anesthesia and extensive instrumentation, the difference in mean arterial pressure between recipients of a kidney from sympathectomized and hydralazine-treated donors was only 10 mmHg and did not reach statistical significance whereas the difference amounted to 20 mmHg in conscious freely moving rats (14) . Renal 
Perspectives
In rats nephrogenesis and the development of renal sympathetic innervation continue through the first two-three postnatal weeks and both processes may influence each other (10, 18, 22, 37) . Activation of -adrenoreceptors reduced renal RNA and protein synthesis in 5-and 9-Page 17 of 33 day-old rats (35) and an elevated sympathetic tone has been suggested to inhibit cell replication in the developing rat kidney (36) . On the other hand, the trophic effects of sympathetic innervation on the cardiovascular system are well established (19, 21).
We provide evidence that neonatal sympathectomy lowers renal NADPH oxidase activity and renal medullary mRNA expression of two major NADPH oxidase subunits. Thus, oxygen radicals do not only activate sympathetic nerve activity in SHR (33) but elevated sympathetic nerve activity may also contribute to enhanced renal oxygen radical formation by increasing NADPH oxidase activity under pathological conditions. Renal vascular resistance was reduced in kidneys from sympathectomized SHR (14) . This effect persisted several weeks after restoration of sympathetic tone by transplantation of these kidneys into untreated SHR.
A role of NADPH oxidase activation in 1 -adrenoceptor-mediated vascular smooth muscle cell growth and proliferation has been shown (2). Conversely, neonatal sympathectomy reduced the media thickness of mesenteric arteries in SHR (21) and lowered rat vascular smooth muscle actin synthesis (6) . A long-term reduction of arterial pressure and renal vascular resistance was also induced with the superoxide dismutase mimetic tempol (32) although tempol effects may not exclusively be due to oxygen radical dismutation (42) .
Activation of the NADPH oxidase by enhanced sympathetic innervation density and activity in SHR (8, 10, 12) may be involved in the programming of elevated renal vascular resistance and contribute to subtle alterations during perinatal programming of renal function that lead to chronic arterial hypertension (17) . Activity is given in relative light units (RLU) per min and mg wet tissue weight.
A: Cortical NADPH oxidase activity in untreated SHR (n = 12, gray bar), sympathectomized SHR (n = 11, black bar), and hydralazine-treated SHR (n = 11, white bar). Asterisk indicates significant difference from untreated and hydralazine-treated aninals (p < 0.01).
B: Medullary NADPH oxidase activity in untreated SHR (n = 10, gray bar), sympathectomized SHR (n = 8, black bar), and hydralazine-treated SHR (n = 9, white bar).
Asterisk indicates significant difference from untreated and hydralazine-treated animals (p < 0.05). renal Na + balance, mmol/100g bw * d 
